Levin Zhu, CEO of China International Capital Corp. and son of former Chinese Premier Zhu Rongji, attends the debut of Sinopharm Group Co. Ltd. at the Hong Kong Stock Exchange September 23, 2009. Shares of Sinopharm Group Co Ltd, China's top pharmaceutical products distributor, rose 23.4 percent in their Hong Kong debut on Wednesday, as investors bet on strong growth for China's healthcare sector. REUTERS/Bobby Yip (CHINA POLITICS BUSINESS HEALTH HEADSHOT)
REUTERS/BOBBY YIP